<DOC>
	<DOC>NCT01201798</DOC>
	<brief_summary>The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of endogenous anterior uveitis.</brief_summary>
	<brief_title>Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis, Anterior</mesh_term>
	<mesh_term>Iridocyclitis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Difluprednate</mesh_term>
	<criteria>Diagnosis of endogenous anterior uveitis in at least 1 eye. The presence of &gt; 10 cells in the anterior chamber of at least one eye, and a flare score of &gt; 2 in that same eye. Age 2 years or older on day of consent. Negative urine pregnancy test on Day 0 for females of childbearing potential who are not at least 1 year postmenopausal or surgically sterilized. Other protocoldefined inclusion criteria may apply. Presence of endogenous anterior uveitis diagnosed for &gt; 2 weeks prior to enrollment in the study. Presence of intermediate uveitis, posterior uveitis or panuveitis in either eye. Instillation of any topical corticosteroid or NSAID in the study eye within 7 days of instillation of study drug. History of glaucoma or clinically significant ocular hypertension in the opinion of the Investigator involving an IOP â‰¥ 21 millimeters mercury in either eye. History of steroidinduced elevation of intraocular pressure. Any confirmed or suspected active viral, bacterial or fungal keratoconjunctival disease in either eye. History of glaucoma or clinically significant ocular hypertension in the opinion of the Investigator involving an intraocular pressure (IOP) &gt; 21 mmHg in either eye. Corneal abrasion or ulceration in either eye. Pregnancy or lactation. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>